Security Defense Systems Sues Athenahealth and ConnectiveRx
Contributed by Knobbe Martens. Originally published on Patexia; republished here as part of the LexDana archive.

Written by: Mengmeng Du
On April 26, 2023, Security Defense Systems, LLC sued Athenahealth, Inc. in the Western District of Texas. The lawsuit alleges that Athenahealth’s Epocrates application and epocrates.com website infringe U.S. Patent No. 8,155,887, titled “Computer Visualized Drug Interaction Information Retrieval,” which issued in 2012.

Athenahealth is a Delaware corporation. Security Defense Systems is based in Wyoming and is currently the sole and exclusive owner of the ’887 Patent, according to the complaint. The sole inventor of the ’887 Patent is Leigh M. Rothschild, who is also listed as the inventor for many other patents according to JUSTIA Patents. The docket for the Security Defense Systems v. Athenahealth case is available here.
The same patent was also asserted in two other district court cases. Six days prior to filing the case against Athenahealth, Security Defense Systems sued PSKW, LLC, d/b/a ConnectiveRx, for infringing the ’887 Patent in the District of New Jersey. The docket for the Security Defense Systems v. PSKW case is available here. In a case filed on June 4, 2020 in the District of Massachusetts, the ’887 Patent was asserted against Irody, Inc. by Drug Information Retrieval System, LLC (“DIRS”). DIRS voluntarily dismissed the Massachusetts complaint before Irody answered or filed motion for summary judgment. The docket for the Drug Information Retrieval System v. Irody case is available here.
More insights

Space Tech Investment Grows in 2026 Amid Congressional Proposals Affecting Contractual IP Rights
Written by : Tom Cowan Key Takeaways : Private investment in space technology continues an upward trend in 2026, with increasing growth in late stage and venture growth deals, including private equity purchases. Against a backdrop of the “dual…
Amendments to Mexico S Federal Law for Protection of Industrial Property Inform More Flexible International Ip Strategy for Biotech Companies
Written by : J ason J. Jardine and Lizzy T. Do Key Takeaway: Amendments to Mexico’s Federal Law for Protection of Industrial Property align more with U.S. Patent and Trademark Office standards for restoring priority and application revival,…
Public Funding for Energy Innovation Impacts Private Intellectual Property Rights
Written by : Kimberly M. Papadantonakis, Ph.D. Key Takeaway : The value of intellectual property developed using government funds depends upon compliance with disclosure and licensing rules. Public investment is critical to the development and…